IDP-124 Lotion

DRUG2 trials

Sponsors

Bausch Health Americas, Inc.

Conditions

Atopic Dermatitis

Phase 3

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)

CompletedNCT03002571

Bausch Health Americas, Inc.Atopic Dermatitis

Start: 2018-07-24End: 2020-04-14Updated: 2023-05-08

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

CompletedNCT03058783

Bausch Health Americas, Inc.Atopic Dermatitis

Start: 2018-08-14End: 2020-05-12Updated: 2023-05-08